Status:
COMPLETED
At Home Spirometry and Video Module Education for COPD Patients
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The central hypothesis is that patients hospitalized for COPD who subsequently complete the at-home BREATHES Program with V-TTG skill training and SpiroPD adherence support will retain increased medic...
Detailed Description
Chronic obstructive pulmonary disease (COPD) results in nearly 750,000 hospitalizations annually and is the third leading cause of 30-day hospital readmissions in the United States.Improving the quali...
Eligibility Criteria
Inclusion
- Age 18 years and older
- Physician-diagnosed COPD (prior to or during hospitalization)
- Owns a wifi-enabled device (desktop, laptop, tablet, smart phone, etc.)
- Discharged with a rescue and/or controller MDI (metered dose inhaler).
Exclusion
- Currently in an intensive care unit
- Physician declines to provide consent
- Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 23 2021
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT03834350
Start Date
April 11 2019
End Date
June 23 2021
Last Update
July 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medicine
Chicago, Illinois, United States, 60637